Observational Study of Patients Suffering From Endometriosis and Adenomyosis
Launched by CHINESE UNIVERSITY OF HONG KONG · Apr 26, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at women who have endometriosis or adenomyosis, which are conditions that can cause chronic pain and other symptoms. The goal of the study is to gather information about the health and quality of life of these women. Researchers will use questionnaires to learn more about their reproductive health and the unique features of their conditions. They want to identify factors that might lead to more severe cases and suggest the best treatment options for different patient groups, whether they wish to have children or not.
To participate in this study, women need to be between 18 and 74 years old and must have a diagnosis of endometriosis or adenomyosis confirmed through an ultrasound or MRI scan. Those who do not wish to participate, are menopausal, or cannot understand the study will not be included. Participants can expect to share their experiences through structured questionnaires and contribute to valuable research that may help improve care and treatment options for women with these conditions in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • with endometriosis or adenomyosis confirmed by ultrasound or MRI
- Exclusion Criteria:
- • refuse to participate in the study, less than 18 years old, menopausal, illiterate or mentally incapable
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Wen Ying Linda FUNG
Principal Investigator
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials